Vaswani Industries Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: October 17, 2025, 10:45 pm

Competitors of Vaswani Industries Ltd

All Competitor Stocks of Vaswani Industries Ltd

Quarterly Result

Last Updated: August 20, 2025, 1:30 am

Below is a detailed analysis of the quarterly data for Vaswani Industries Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:

• For Sales, as of Jun 2025, the value is 114.28 Cr.. The value appears to be declining and may need further review. It has decreased from 115.40 Cr. (Mar 2025) to 114.28 Cr., marking a decrease of 1.12 Cr..
• For Expenses, as of Jun 2025, the value is 104.59 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 105.52 Cr. (Mar 2025) to 104.59 Cr., marking a decrease of 0.93 Cr..
• For Operating Profit, as of Jun 2025, the value is 9.69 Cr.. The value appears to be declining and may need further review. It has decreased from 9.88 Cr. (Mar 2025) to 9.69 Cr., marking a decrease of 0.19 Cr..
• For OPM %, as of Jun 2025, the value is 8.48%. The value appears to be declining and may need further review. It has decreased from 8.56% (Mar 2025) to 8.48%, marking a decrease of 0.08%.
• For Other Income, as of Jun 2025, the value is 0.31 Cr.. The value appears strong and on an upward trend. It has increased from -2.01 Cr. (Mar 2025) to 0.31 Cr., marking an increase of 2.32 Cr..
• For Interest, as of Jun 2025, the value is 3.17 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 3.64 Cr. (Mar 2025) to 3.17 Cr., marking a decrease of 0.47 Cr..
• For Depreciation, as of Jun 2025, the value is 1.47 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 1.11 Cr. (Mar 2025) to 1.47 Cr., marking an increase of 0.36 Cr..
• For Profit before tax, as of Jun 2025, the value is 5.36 Cr.. The value appears strong and on an upward trend. It has increased from 3.12 Cr. (Mar 2025) to 5.36 Cr., marking an increase of 2.24 Cr..
• For Tax %, as of Jun 2025, the value is -2.05%. The value appears to be improving (decreasing) as expected. It has decreased from 36.22% (Mar 2025) to -2.05%, marking a decrease of 38.27%.
• For Net Profit, as of Jun 2025, the value is 5.47 Cr.. The value appears strong and on an upward trend. It has increased from 1.99 Cr. (Mar 2025) to 5.47 Cr., marking an increase of 3.48 Cr..
• For EPS in Rs, as of Jun 2025, the value is 1.75. The value appears strong and on an upward trend. It has increased from 0.63 (Mar 2025) to 1.75, marking an increase of 1.12.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: October 15, 2025, 4:11 am

Growth

Last Updated: September 5, 2025, 1:51 pm

Balance Sheet

Last Updated: June 16, 2025, 11:07 am

Below is a detailed analysis of the balance sheet data for Vaswani Industries Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Equity Capital, as of Mar 2025, the value is 31.00 Cr.. The value appears strong and on an upward trend. It has increased from 30.00 Cr. (Mar 2024) to 31.00 Cr., marking an increase of 1.00 Cr..
• For Reserves, as of Mar 2025, the value is 106.00 Cr.. The value appears strong and on an upward trend. It has increased from 92.00 Cr. (Mar 2024) to 106.00 Cr., marking an increase of 14.00 Cr..
• For Borrowings, as of Mar 2025, the value is 156.00 Cr.. The value appears to be increasing, which may not be favorable. However, Borrowings exceed Reserves, which may signal higher financial risk. It has increased from 33.00 Cr. (Mar 2024) to 156.00 Cr., marking an increase of 123.00 Cr..
• For Other Liabilities, as of Mar 2025, the value is 68.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 34.00 Cr. (Mar 2024) to 68.00 Cr., marking an increase of 34.00 Cr..
• For Total Liabilities, as of Mar 2025, the value is 362.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 189.00 Cr. (Mar 2024) to 362.00 Cr., marking an increase of 173.00 Cr..
• For Fixed Assets, as of Mar 2025, the value is 112.00 Cr.. The value appears strong and on an upward trend. It has increased from 52.00 Cr. (Mar 2024) to 112.00 Cr., marking an increase of 60.00 Cr..
• For CWIP, as of Mar 2025, the value is 67.00 Cr.. The value appears strong and on an upward trend. It has increased from 4.00 Cr. (Mar 2024) to 67.00 Cr., marking an increase of 63.00 Cr..
• For Investments, as of Mar 2025, the value is 2.00 Cr.. The value appears to be declining and may need further review. It has decreased from 7.00 Cr. (Mar 2024) to 2.00 Cr., marking a decrease of 5.00 Cr..
• For Other Assets, as of Mar 2025, the value is 180.00 Cr.. The value appears strong and on an upward trend. It has increased from 126.00 Cr. (Mar 2024) to 180.00 Cr., marking an increase of 54.00 Cr..
• For Total Assets, as of Mar 2025, the value is 362.00 Cr.. The value appears strong and on an upward trend. It has increased from 189.00 Cr. (Mar 2024) to 362.00 Cr., marking an increase of 173.00 Cr..

However, the Borrowings (156.00 Cr.) are higher than the Reserves (106.00 Cr.), which may signal higher financial risk.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Free Cash Flow

Financial Efficiency Indicators

Share Holding Pattern

Key Financial Ratios

After reviewing the key financial ratios for Vaswani Industries Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
• For Basic EPS (Rs.), as of Mar 25, the value is 2.81. This value is below the healthy minimum of 5. It has decreased from 3.01 (Mar 24) to 2.81, marking a decrease of 0.20.
• For Diluted EPS (Rs.), as of Mar 25, the value is 2.81. This value is below the healthy minimum of 5. It has decreased from 3.01 (Mar 24) to 2.81, marking a decrease of 0.20.
• For Cash EPS (Rs.), as of Mar 25, the value is 4.15. This value is within the healthy range. It has decreased from 4.26 (Mar 24) to 4.15, marking a decrease of 0.11.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 43.86. It has increased from 38.00 (Mar 24) to 43.86, marking an increase of 5.86.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 43.86. It has increased from 40.55 (Mar 24) to 43.86, marking an increase of 3.31.
• For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 131.32. It has increased from 129.78 (Mar 24) to 131.32, marking an increase of 1.54.
• For PBDIT / Share (Rs.), as of Mar 25, the value is 9.28. This value is within the healthy range. It has increased from 7.93 (Mar 24) to 9.28, marking an increase of 1.35.
• For PBIT / Share (Rs.), as of Mar 25, the value is 7.88. This value is within the healthy range. It has increased from 6.68 (Mar 24) to 7.88, marking an increase of 1.20.
• For PBT / Share (Rs.), as of Mar 25, the value is 4.20. This value is within the healthy range. It has increased from 4.11 (Mar 24) to 4.20, marking an increase of 0.09.
• For Net Profit / Share (Rs.), as of Mar 25, the value is 2.74. This value is within the healthy range. It has decreased from 3.01 (Mar 24) to 2.74, marking a decrease of 0.27.
• For PBDIT Margin (%), as of Mar 25, the value is 7.06. This value is below the healthy minimum of 10. It has increased from 6.11 (Mar 24) to 7.06, marking an increase of 0.95.
• For PBIT Margin (%), as of Mar 25, the value is 5.99. This value is below the healthy minimum of 10. It has increased from 5.14 (Mar 24) to 5.99, marking an increase of 0.85.
• For PBT Margin (%), as of Mar 25, the value is 3.19. This value is below the healthy minimum of 10. It has increased from 3.16 (Mar 24) to 3.19, marking an increase of 0.03.
• For Net Profit Margin (%), as of Mar 25, the value is 2.09. This value is below the healthy minimum of 5. It has decreased from 2.32 (Mar 24) to 2.09, marking a decrease of 0.23.
• For Return on Networth / Equity (%), as of Mar 25, the value is 6.25. This value is below the healthy minimum of 15. It has decreased from 7.92 (Mar 24) to 6.25, marking a decrease of 1.67.
• For Return on Capital Employeed (%), as of Mar 25, the value is 9.52. This value is below the healthy minimum of 10. It has decreased from 13.72 (Mar 24) to 9.52, marking a decrease of 4.20.
• For Return On Assets (%), as of Mar 25, the value is 2.37. This value is below the healthy minimum of 5. It has decreased from 4.78 (Mar 24) to 2.37, marking a decrease of 2.41.
• For Long Term Debt / Equity (X), as of Mar 25, the value is 0.79. This value is within the healthy range. It has increased from 0.12 (Mar 24) to 0.79, marking an increase of 0.67.
• For Total Debt / Equity (X), as of Mar 25, the value is 1.14. This value exceeds the healthy maximum of 1. It has increased from 0.28 (Mar 24) to 1.14, marking an increase of 0.86.
• For Asset Turnover Ratio (%), as of Mar 25, the value is 1.49. It has decreased from 2.00 (Mar 24) to 1.49, marking a decrease of 0.51.
• For Current Ratio (X), as of Mar 25, the value is 1.53. This value is within the healthy range. It has decreased from 2.63 (Mar 24) to 1.53, marking a decrease of 1.10.
• For Quick Ratio (X), as of Mar 25, the value is 0.89. This value is below the healthy minimum of 1. It has decreased from 1.55 (Mar 24) to 0.89, marking a decrease of 0.66.
• For Inventory Turnover Ratio (X), as of Mar 25, the value is 5.37. This value is within the healthy range. It has decreased from 6.09 (Mar 24) to 5.37, marking a decrease of 0.72.
• For Interest Coverage Ratio (X), as of Mar 25, the value is 3.64. This value is within the healthy range. It has increased from 3.09 (Mar 24) to 3.64, marking an increase of 0.55.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 2.52. This value is below the healthy minimum of 3. It has increased from 2.17 (Mar 24) to 2.52, marking an increase of 0.35.
• For Enterprise Value (Cr.), as of Mar 25, the value is 220.84. It has increased from 103.98 (Mar 24) to 220.84, marking an increase of 116.86.
• For EV / Net Operating Revenue (X), as of Mar 25, the value is 0.53. This value is below the healthy minimum of 1. It has increased from 0.26 (Mar 24) to 0.53, marking an increase of 0.27.
• For EV / EBITDA (X), as of Mar 25, the value is 7.59. This value is within the healthy range. It has increased from 4.37 (Mar 24) to 7.59, marking an increase of 3.22.
• For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 0.26. This value is below the healthy minimum of 1. It has increased from 0.24 (Mar 24) to 0.26, marking an increase of 0.02.
• For Price / BV (X), as of Mar 25, the value is 0.79. This value is below the healthy minimum of 1. It has decreased from 0.82 (Mar 24) to 0.79, marking a decrease of 0.03.
• For Price / Net Operating Revenue (X), as of Mar 25, the value is 0.26. This value is below the healthy minimum of 1. It has increased from 0.24 (Mar 24) to 0.26, marking an increase of 0.02.
• For EarningsYield, as of Mar 25, the value is 0.07. This value is below the healthy minimum of 5. It has decreased from 0.09 (Mar 24) to 0.07, marking a decrease of 0.02.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness